The Impact of a Partially Effective HIV Vaccine on a Population of Intravenous Drug Users in Bangkok, Thailand: A Dynamic Model

&NA; Because of the variability of HIV, the first AIDS vaccine is likely to be only partially effective. There is some concern among scientists that a low‐efficacy vaccine could worsen the HIV epidemic if vaccinated individuals increase their risk behavior under the false assumption of immunity. To address this concern, we constructed a dynamic compartmental model that simulated the course of the HIV/AIDS epidemic in a population of injection drug users in Bangkok, Thailand. The model calculated long‐term HIV prevalence, number of AIDS cases, and total population size for two scenarios: vaccination program versus no vaccination program. We used sensitivity analyses to evaluate the impact of postvaccination risk behavior change on HIV prevalence. A 75% effective vaccine led to a 40‐year HIV prevalence of 37% with vaccination and 50% without vaccination. Postvaccination behavior change had only a limited effect on the results with a 75% effective vaccine but a significant effect with a 30% effective vaccine. If 90% of low‐risk individuals responded to a 30% effective vaccine with increased high‐risk behavior, the benefit of vaccination disappeared. These results agree with analyses of the epidemic among gay men. If injection drug behavior is indeed modifiable, our findings have significant policy and planning implications.

[1]  T. Mastro,et al.  Estimating the number of HIV-infected injection drug users in Bangkok: a capture--recapture method. , 1994, American journal of public health.

[2]  J. Kaewkungwal,et al.  Survival of AIDS patients in the emerging epidemic in Bangkok, Thailand. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[3]  D. Simpson,et al.  Mortality rates among opioid addicts in a longitudinal study. , 1987, American journal of public health.

[4]  E H Kaplan,et al.  A model-based estimate of HIV infectivity via needle sharing. , 1992, Journal of acquired immune deficiency syndromes.

[5]  D. D. Des Jarlais,et al.  Risk factors and HIV seropositivity among injecting drug users in Bangkok. , 1991, AIDS.

[6]  A. Abdul-Quader,et al.  Crack use and multiple AIDS risk behaviors. , 1991, Journal of acquired immune deficiency syndromes.

[7]  H V Fineberg,et al.  Bleach programs for preventing AIDS among i.v. drug users: modeling the impact of HIV prevalence. , 1991, American journal of public health.

[8]  R. Anderson,et al.  Low-efficacy HIV vaccines: potential for community-based intervention programmes , 1996, The Lancet.

[9]  Douglas K Owens,et al.  Screening Women of Childbearing Age for Human Immunodeficiency Virus: A Model-Based Policy Analysis , 1993 .

[10]  D. D. Des Jarlais,et al.  Infection with HIV-1 subtypes B and E in injecting drug users screened for enrollment into a prospective cohort in Bangkok, Thailand. , 1998, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[11]  K. Käll,et al.  HIV status and changes in risk behaviour among intravenous drug users in Stockholm 1987-1988. , 1990, AIDS.

[12]  G. Orth,et al.  Comparative prevalence, incidence and short‐term prognosis of cervical squamous intraepithelial lesions amongst HIV‐positive and HIV‐negative women , 1998, AIDS.

[13]  S. Blower,et al.  Prophylactic vaccines, risk behavior change, and the probability of eradicating HIV in San Francisco. , 1994, Science.

[14]  J. Kahn,et al.  Risk behavior for HIV infection in participants in preventive HIV vaccine trials: a cautionary note. , 1997, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[15]  David R. Holtgrave,et al.  Cost-effectiveness of post-exposure prophylaxis following sexual exposure to HIV. , 1998 .

[16]  D. D. Des Jarlais,et al.  HIV testing and sexual behavior among intravenous drug users in Bangkok, Thailand. , 1992, Journal of acquired immune deficiency syndromes.

[17]  Ross D. Shachter,et al.  A Dynamic HIV-Transmission Model for Evaluating the Costs and Benefits of Vaccine Programs , 1998, Interfaces.

[18]  E H Kaplan,et al.  Needles that kill: modeling human immunodeficiency virus transmission via shared drug injection equipment in shooting galleries. , 1989, Reviews of infectious diseases.

[19]  S. Vermund,et al.  HIV Vaccine Development: A Progress Report , 1994, Annals of Internal Medicine.

[20]  S. Friedman,et al.  AIDS risk reduction and reduced HIV seroconversion among injection drug users in Bangkok. , 1994, American journal of public health.